Author

A. Birbrair

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2 Research Focus:development & morphogenesis· 2 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1

Frequent Co-Authors

A. Bedard· 1 shared A. Guilherme· 1 shared A. R. Nobre· 1 shared B. Naume· 1 shared D. K. Singh· 1 shared E. Risson· 1 shared F. Franco· 1 shared F. Henriques· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bedard

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Periosteal skeletal stem cells can migrate into the bone marrow and support hematopoiesis after injury

T. Marchand, K. E. Akinnola, S. Takeishi, M. Maryanovich, S. Pinho, J. Saint-Vanne, A. Birbrair, T. Lamy, K. Tarte, P. Frenette, K. Gritsman

bioRxiv · Jan 12, 2023Cell Biology

NG2+/Nestin+ mesenchymal stem cells dictate DTC dormancy in the bone marrow through TGFβ2

A. R. Nobre, E. Risson, D. K. Singh, J. S. Di Martino, J. F. Cheung, J. Wang, J. Johnson, H. G. Russnes, J. J. Bravo-Cordero, A. Birbrair, B. Naume, M. Azhar, P. S. Frenette, J. A. Aguirre-Ghiso

This study shows NG2+/Nestin+ mesenchymal stem cells in the bone marrow use TGFβ2 to induce dormancy in breast cancer disseminated tumor cells.

bioRxiv · Oct 22, 2020Cancer Biology

Toll-Like Receptor-4 Disruption Suppresses Adipose Tissue Remodeling and Increases Survival During Cancer Cachexia Syndrome

F. Henriques, M. Lopes, F. Franco, P. Knobl, K. Santos, L. Bueno, V. Correa, A. Bedard, A. Guilherme, A. Birbrair, S. Peres, S. Farmer, M. L. Batista

This study shows that disrupting TLR4 reduces adipose tissue remodeling and improves survival in cancer cachexia by inhibiting inflammation and macrophage infiltration.

bioRxiv · Aug 25, 2018Cancer Biology